La línia de recerca està centrada en l’estudi de les bases moleculars de lesió cel·lular a la diabetis i les seves condicions metabòliques associades tant en models experimentals cel·lulars i animals com en humans.
La línia de recerca està centrada en l’estudi de les bases moleculars de lesió cel·lular a la diabetis i les seves condicions metabòliques associades tant en models experimentals cel·lulars i animals com en humans.
MAURICIO PUENTE, DIEGO FGS
dmauricio@santpau.cat
Abraldes Zayas, Natalia FGS
Aguilar Galvez, Xavier FGS
Boluda Sanson, Alejandro IR
Chico Ballesteros, Ana Isabel FGS
Corcoy Pla, Rosa FGS
Cubero Marcos, Jose Maria FGS
Cuixart Carruesco, Gemma IR
Doria Cervos, Montserrat FGS
Fernandez Camins, Berta IR
Garcia Patterson, Apolonia Gabriela IR
Genua Trullos, Idoia, FGS
Gonzalez Blanco, Cintia FGS
Julve Gil, Josep IR
Lopez Argudo, Alicia FGS
Martinez Mores, Santiago IR
Mato Matute, Eugenia CIBERBBN
Mendoza Mathison, Lilian Cristina FGS
Miñambres Donaire, Inka FGS
Miranda Olivos, Romina Andrea IR
Perez Perez, Antonio FGS
Rojo Lopez, Marina Idalia IR
Rossell Rusiñol, Joana CIBERDEM
Sarda Simo, Helena FGS
Tundidor Rengel, Diana FGS
Vlacho Bogdan, CIBERDEM
(JIF 2023)
-Alcubierre N, Granado M, Bogdanov P, Hernandez C, Ramos H, Castelblanco E, Real J, Rubinat E, Traveset A, Hernandez M, Jurjo C, Vioque J, Navarrete EM, Simo R, Mauricio D. Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies. Nutrients. 2023; 15(5):1169. DOI:10.3390/nu15051169. PMID:36904168. IF:4,800 (Q1/2D). Document type: Article.
-Ampudia FJ, Ugarte E, Chico A, García J, Galan M. Spanish Consensus on the Use of isCGM in the Management of Patients With Insulin Therapy: The MONITOR Project. Journal Of Diabetes Science And Technology. 2023; 17(5):19322968221087270. DOI:10.1177/19322968221087270. PMID:35466722. IF:4,100 (Q2/3D). Document type: Article.
-Arrobas T, Guijarro C, Campuzano R, Rodríguez M, Valderrama JF, Pérez A, Botana MA, Morais A, García JA, Obaya JC, Castilla L, Pallares V, Egocheaga I, Salgueira M, Castellanos MM, Mostaza JM, Gómez JJ, Buño A, en representacion Y. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. Endocrinologia Diabetes y Nutricion. 2023; 70(7). DOI:10.1016/j.endinu.2023.02.002. IF:1,800 (Q3/8D). Document type: Article.
-Arrobas T, Guijarro C, Campuzano R, Rodríguez M, Valderrama JF, Pérez A, Botana MA, Morais A, García JA, Obaya JC, Castilla L, Pallares V, Egocheaga I, Salgueira M, Castellanos MM, Mostaza JM, Gómez JJ, Buño A, en representacion Y. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. Cirugia Cardiovascular. 2023; 30(3). DOI:10.1016/j.circv.2023.02.001. IF:0,300 (Q4/10D). Document type: Article.
-Arrobas T, Guijarro C, Campuzano R, Rodríguez M, Valderrama JF, Pérez A, Botana MA, Morais A, García JA, Obaya JC, Castilla L, Pallares V, Egocheaga I, Salgueira M, Castellanos MM, Mostaza JM, Gómez JJ, Buño A, en representacion Y. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. Rec: Cardioclinics. 2023; 58(2). DOI:10.1016/j.rccl.2022.11.004. Document type: Article.
-Arrobas T, Guijarro C, Campuzano R, Rodríguez M, Valderrama JF, Pérez A, Botana MA, Morais A, García JA, Obaya JC, Castilla L, Pallares V, Egocheaga I, Salgueira M, Castellanos MM, Mostaza JM, Gómez JJ, Buño A, en representacion Y. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. REVISTA CLINICA ESPANOLA. 2023; 223(7). DOI:10.1016/j.rce.2022.11.001. PMID:37302464. IF:2,300 (Q2/3D). Document type: Article.
-Arrobas T, Guijarro C, Campuzano R, Rodríguez M, Valderrama JF, Pérez A, Botana MA, Morais A, García JA, Obaya JC, Castilla L, Pallares V, Egocheaga I, Salgueira M, Castellanos MM, Mostaza JM, Gómez JJ, Buño A. Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles: ¿qué parámetros debe incluir un perfil lipídico básico?. ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO. 2023; 4(2). DOI:10.1515/almed-2023-0010. IF:1,100 (Q4/8D). Document type: Article.
-Battelino T, Alexander CM, Amiel SA, Arreaza G, Beck RW, Bergenstal RM, Buckingham BA, Carroll J, Ceriello A, Chow E, Choudhary P, Close K, Danne T, Dutta S, Gabbay R, Garg S, Heverly J, Hirsch IB, Kader T, Kenney J, Kovatchev B, Laffel L, Maahs D, Mathieu C, Mauricio D, Nimri R, Nishimura R, Scharf M, Del Prato S, Renard E, Rosenstock J, Saboo B, Ueki K, Umpierrez GE, Weinzimer SA, Phillip M. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes & Endocrinology. 2023; 11(1). DOI:10.1016/S2213-8587(22)00319-9. PMID:36493795. IF:44,000 (Q1/1D). Document type: Review.
-Bellido V, Freckman G, Pérez A, Galindo RJ. Accuracy and Potential Interferences of Continuous Glucose Monitoring Sensors in the Hospital. Endocrine Practice. 2023; 29(11). DOI:10.1016/j.eprac.2023.06.007. PMID:37369291. IF:3,700 (Q2/4D). Document type: Review.
-Bellon F, Solà I, Gimenez G, Hernández M, Metzendorf MI, Rubinata E, Mauricio D. Perioperative glycaemic control for people with diabetes undergoing surgery. Cochrane Database of Systematic Reviews. 2023; (8):CD007315. DOI:10.1002/14651858.CD007315.pub3. PMID:37526194. IF:8,800 (Q1/1D). Document type: Review.
-Bermudez M, Marti M, Castro E, Bretones MD, Farras C, Gonzalez J, Pamplona R, Lecube A, Mauricio D, Cambray S, Valdivielso JM, Fernandez E, ILERVAS C. Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study. ATHEROSCLEROSIS. 2023; 375. DOI:10.1016/j.atherosclerosis.2023.05.002. PMID:37276714. IF:4,900 (Q1/2D). Document type: Article.
-Bundo M, Vlacho B, Llussa J, Bobe I, Aivar M, Ciria C, Martinez A, Real J, Mata M, Cos X, Doria M, Viade J, Franch J, Mauricio D. Prediction of outcomes in subjects with type 2 diabetes and diabetic foot ulcers in Catalonian primary care centers: a multicenter observational study. Journal of Foot and Ankle Research. 2023; 16(1):8. DOI:10.1186/s13047-023-00602-6. PMID:36849888. IF:2,500 (Q1/3D). Document type: Article.
-Canyelles M, Blanco F, Pérez A, Escolà JC. Comment on Huh et al. Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study. Diabetes Care 2023;46:305-312. DIABETES CARE. 2023; 46(10):e203. DOI:10.2337/dc23-0774. PMID:37729500. IF:14,800 (Q1/1D). Document type: Letter.
-Chico A, de Solis SN, Lainez M, Rius F, Cuesta M. Efficacy, Safety, and Satisfaction with the Accu-Chek Insight with Diabeloop Closed-Loop System in Subjects with Type 1 Diabetes: A Multicenter Real-World Study. Diabetes Technology & Therapeutics. 2023; 25(4). DOI:10.1089/dia.2022.0449. PMID:36724301. IF:5,700 (Q1/2D). Document type: Article.
-Chico A, Moreno J, Fernández D, Solá E. The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization. Diabetes Therapy. 2023; 15(1). DOI:10.1007/s13300-023-01486-2. PMID:37857988. IF:2,800 (Q3/6D). Document type: Article.
-Corral M, Arpa B, Rosell E, Egia L, Mora C, Stratmann T, Sanchez A, Casanovas A, Esquerda JE, Mauricio D, Vives M, Verdaguer J. NOD mouse dorsal root ganglia display morphological and gene expression defects before and during autoimmune diabetes development. Frontiers in Endocrinology. 2023; 14:1176566. DOI:10.3389/fendo.2023.1176566. PMID:37334284. IF:3,900 (Q2/3D). Document type: Article.
-Dieberger AM, Obermayer B, Harreiter J, Desoye G, van MNM, Simmons D, Corcoy R, Perez JMA, Kautzky A, Damm P, Mathiesen E, Jensen DM, Andersen LLT, Dunne F, Lapolla A, Dalfra MG, Bertolotto A, Jelsma JGM, Galjaard S, Wender E, Zawiejska A, Hill D, Devlieger R, Snoek FJ, DALI Core Investigator G. Physical activity and sedentary time across pregnancy and associations with neonatal weight, adiposity and cord blood parameters: a secondary analysis of the DALI study. INTERNATIONAL JOURNAL OF OBESITY. 2023; 47(9). DOI:10.1038/s41366-023-01347-9. PMID:37500924. IF:4,200 (Q1/3D). Document type: Article.
-Escalada J, Pérez A, Rica I. Is the Spanish type 1 diabetes mellitus registry really necessary?. Endocrinologia Diabetes y Nutricion. 2023; 70(10). DOI:10.1016/j.endinu.2023.05.002. PMID:38000969. IF:1,800 (Q3/8D). Document type: Article.
-Falkenhain D, Muniesa C, Estrach MT, Morillo M, Peñate Y, Acebo E, Pujol RM, García MP, Machan S, Medina S, Botella R, Fernández de Misa R, Blanes M, Flórez A, Pérez G, Izu R, Yanguas I, Silva E, Pérez A, Prieto L, Zayas A, Parera ME, Pérez A, Aspe L, Román C, Sánchez MP, Bassas J, Domínguez JD, Calzado L, Navedo M, Ortiz A, Servitje O, Polo I, Torres I, Hernández MN, Mitxelena J, García A, García I, Ortiz PL. Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years. Actas Dermo-Sifiliograficas. 2023; 114(4). DOI:10.1016/j.ad.2022.11.010. PMID:36529273. IF:3,800 (Q1/2D). Document type: Article.
-Frontino G, Succurro E, Corcoy R, Scialabba F, Poloniato A, Scavini M. Current and future trends in gestational diabetes diagnosis, care and neonatal outcomes. Frontiers in Endocrinology. 2023; 14:1270472. DOI:10.3389/fendo.2023.1270472. PMID:38098867. IF:3,900 (Q2/3D). Document type: Editorial Material.
-García A, Balsells M, Solà I, Gich I, Corcoy R. Impact of gestational diabetes mellitus treatment on medium/long-term outcomes after pregnancy: A systematic review and meta-analysis. DIABETIC MEDICINE. 2023; 40(1):e14998. DOI:10.1111/dme.14998. PMID:36326694. IF:3,200 (Q2/5D). Document type: Article.
-García E, Gil P, Miñambres I, Benitez A, Rodríguez C, Claudi L, Julve J, Benitez S, Sánchez JL, Rives J, Garcia X, Vilades D, Perez A, Llorente V. Increased sLRP1 and decreased atrial natriuretic peptide plasma levels in newly diagnosed T2DM patients are normalized after optimization of glycemic control. Frontiers in Endocrinology. 2023; 14:1236487. DOI:10.3389/fendo.2023.1236487. PMID:37635956. IF:3,900 (Q2/3D). Document type: Article.
-Genua I, Iruzubieta P, Rodríguez JC, Pérez A, Crespo J. NAFLD and type 2 diabetes: A practical guide for the joint management. Gastroenterologia y Hepatologia. 2023; 46(10). DOI:10.1016/j.gastrohep.2022.12.002. PMID:36584750. IF:2,200 (Q3/6D). Document type: Review.
-Giannella A, Castelblanco E, Zambon CF, Basso D, Hernandez M, Ortega E, Alonso N, Mauricio D, Avogaro A, Ceolotto G, Vigili de Kreutzenberg S. Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes. DIABETES CARE. 2023; 46(3). DOI:10.2337/dc22-1441. PMID:36577032. IF:14,800 (Q1/1D). Document type: Article.
-Giménez G, Vinals C, Mata M, Vlacho B, Real J, Franch J, Ortega E, Mauricio D. Epidemiology of the first-ever cardiovascular event in people with type 1 diabetes: a retrospective cohort population-based study in Catalonia. Cardiovascular Diabetology. 2023; 22(1):179. DOI:10.1186/s12933-023-01917-1. PMID:37452416. IF:8,500 (Q1/1D). Document type: Article.
-Goh SY, Kosiborod MN, Lam CSP, Cavender MA, Kohsaka S, Norhammar A, Birkeland KI, Holl RW, Mauricio D, Tangri N, Shaw JE, Thuresson M, Fenici P, Kim DJ, REAL Investigators Study CVDGRP. Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study. DIABETES OBESITY & METABOLISM. 2023; 25(8). DOI:10.1111/dom.15092. PMID:37055714. IF:5,400 (Q1/2D). Document type: Letter.
-Gomez F, Menendez E, Conde S, Conget I, Novials A, Olmedo IS, Tinahones F, San Laureano FC, de la Torre ML, Carazo AM, Hospital J, Nivela OB, Menendez E, Cosmas LM, Payeras F, Gomez IL, Bayo J, Montalban C, Gomez F, de Luis D, Diaz G, Lopez A, Santos E, Jimenez LML, Alvarez V, Samper BB, Ballesteros AC, Gomez BD, Conget I, Perez M, Soldevila B, Flores IC, Garcia MH, Ricart W, Colet AM, Biescas EC, Ampudia FJ, Hernandez A, Sanchez C, Pico A, Escribano JRD, Montanana CF, Pedro T, Abellan P, Rossetti P, Morales FM, Enciso F, Gonzalez AS, Guerrero DB, Cano RL, Lopez JMG, Melero V, Martin J, Mira SA, Serrano MB, Sanfiel MB, Pascual AC, Gomez FJD, Fernandez M, Illan F, Martinez A, Llenas LF, Gaztambide S, Gomez CRF, Oleaga A, de Salinas M, Lopez JP, Gomez AL, Sancho A, Lozano MF, Galan IR, Caimari M, Cardona R, Leon MC, Gonzalez GC, Diez F, Rodriguez PC, Roldan B, del Villar NGP, Perez PR, Rica I, Lopez ID, SED SED1 Study I. Physical activity patterns in type 1 diabetes in Spain: The SED1 study. BMC Sports Science Medicine and Rehabilitation. 2023; 15(1):92. DOI:10.1186/s13102-023-00695-3. PMID:37491278. IF:2,100 (Q1/3D). Document type: Article.
-Gracia A, Lopez A, Lazaro JL, Perez A, Pomares FJ, Fernandez LM, Gil VF, Chicharro E. Consensus-based recommendations on physical activity and exercise in patients with diabetes at risk of foot ulcerations: a Delphi study. Brazilian Journal of Physical Therapy. 2023; 27(2):100500. DOI:10.1016/j.bjpt.2023.100500. PMID:37079949. IF:3,100 (Q1/1D). Document type: Article.
-Iruzubieta P, Bataller R, Arias MT, Arrese M, Calleja JL, Castro G, Cusi K, Dillon JF, Martinez ML, Mateo M, Perez A, Rinella ME, Romero M, Schattenberg JM, Zelber S, Crespo J, Lazarus JV. Research Priorities for Precision Medicine in NAFLD. Clinics in Liver Disease. 2023; 27(2). DOI:10.1016/j.cld.2023.01.016. PMID:37024222. IF:2,900 (Q2/5D). Document type: Article.
-Jayaraman S, Pérez A, Miñambres I, Sánchez JL, Gursky O. LDL binding to cell receptors and extracellular matrix is proatherogenic in obesity but improves after bariatric surgery. JOURNAL OF LIPID RESEARCH. 2023; 64(11):100451. DOI:10.1016/j.jlr.2023.100451. PMID:37777014. IF:5,000 (Q1/3D). Document type: Article.
-Julián MT, Ballesta S, Pera G, Pérez A, Soldevila B, Caballería L, Morillas R, Expósito C, Martínez–Escudé A, Puig M, Franch J, Torán P, Cusi K, Julve J, Mauricio D, Alonso N. Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study. Frontiers in Endocrinology. 2023; 13:1051958. DOI:10.3389/fendo.2022.1051958. PMID:36714592. IF:3,900 (Q2/3D). Document type: Article.
-Julve J, Genua I, Quifer P, Yanes O, Barranco M, Hernandez M, Junza A, Capellades J, Granado M, Alonso N, Castelblanco E, Mauricio D. Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control. DIABETES RESEARCH AND CLINICAL PRACTICE. 2023; 197:110578. DOI:10.1016/j.diabres.2023.110578. PMID:36804334. IF:6,100 (Q1/2D). Document type: Article.
-Ling S, Zaccardi F, Vlacho B, Li P, Gatius JR, Mata M, Franch J, Kosiborod MN, Gillies C, Fenici P, Mauricio D, Shah BR, Khunti K. All-cause and cardiorenal mortality in 6 million adults with and without type 2 diabetes: A comparative, trend analysis in Canada, Spain, and the UK. DIABETES OBESITY & METABOLISM. 2023; 25(1). DOI:10.1111/dom.14856. PMID:36056765. IF:5,400 (Q1/2D). Document type: Article.
-López A, Padro T, Villaplana VD, Muñoz N, Pérez A, Vilahur G, Badimon L. Vascular and Platelet Effects of Tomato Soffritto Intake in Overweight and Obese Subjects. Nutrients. 2023; 15(24):5084. DOI:10.3390/nu15245084. PMID:38140343. IF:4,800 (Q1/2D). Document type: Article.
-Mangas N, Mateu M, Martinez MJ, Lopez A, Pujol I, Martinez C, Corcoy R. Hybrid closed-loop systems can help patients with extreme fear of hypoglycemia or hyperglycemia. Hormones-International Journal of Endocrinology and Metabolism. 2023; 22(3). DOI:10.1007/s42000-023-00451-9. PMID:37198528. IF:2,400 (Q3/7D). Document type: Article.
-Masson W, Barbagelata L, Godinez E, Genua I, Nogueira JP. Association between hepatic steatosis and lipoprotein(a) levels in non-alcoholic patients: A systematic review. Indian Journal Of Gastroenterology. 2023; DOI:10.1007/s12664-023-01457-2. PMID:38036914. IF:2,000 (Q3/7D). Document type: Review.
-Mathiesen ER, Alibegovic AC, Corcoy R, Dunne F, Feig DS, Hod M, Jia T, Kalyanam B, Kar S, Kautzky A, Marchesini C, Rea RD, Damm P, EXPECT G. Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open-label, multinational, randomised, controlled, non-inferiority trial. Lancet Diabetes & Endocrinology. 2023; 11(2). DOI:10.1016/S2213-8587(22)00307-2. PMID:36623517. IF:44,000 (Q1/1D). Document type: Article.
-Mauricio D, Gratacòs M, Franch J. Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves. Cardiovascular Diabetology. 2023; 22(1):314. DOI:10.1186/s12933-023-02056-3. PMID:37968679. IF:8,500 (Q1/1D). Document type: Review.
-Mauricio D, Vlacho B, Ortega E, Cos X, Mata M, Real J, Fernandez B, Franch J. Outcome of COVID-19 infection in people with diabetes mellitus or obesity in the primary care setting in Catalonia, Spain: A retrospective cohort study of the initial three waves. Primary Care Diabetes. 2023; 17(1). DOI:10.1016/j.pcd.2022.12.002. PMID:36528549. IF:2,600 (Q1/3D). Document type: Article.
-Mendoza LC, Tashkova M, Corcoy R, Dornhorst A. Pregnancy induces longitudinal changes in urinary C-peptide creatinine ratio in women with type 1 diabetes. DIABETIC MEDICINE. 2023; 41(1):e15154. DOI:10.1111/dme.15154. PMID:37227744. IF:3,200 (Q2/5D). Document type: Article.
-Miñambres I, de Hollanda A, Vilarrasa N, Pellitero S, Rubio MA, Flores L, Caixàs A, Lobo S, Martinez JI, Acevedo B, Moizé V, Andreu A, Escalada J, S, S, S, A, S, S. Obesity and fertility. Position statement. Endocrinologia Diabetes y Nutricion. 2023; 70. DOI:10.1016/j.endinu.2022.10.002. IF:1,800 (Q3/8D). Document type: Article.
-Miñambres I, de Hollanda A, Vilarrasa N, Pellitero S, Rubio MA, Flores L, Caixàs A, Lobo S, Martinez JI, Acevedo B, Moizé V, Andreu A, Escalada J, S. Obesity and fertility. Position statement. Endocrinologia Diabetes y Nutricion. 2023; 70 Suppl 1. DOI:10.1016/j.endien.2023.03.003. PMID:36907798. IF:1,800 (Q3/8D). Document type: Article.
-Mollo A, Vlacho B, Gratacos M, Mata M, Rubinat E, Berenguera A, Real J, Puig R, Cos X, Franch J, Khunti K, Mauricio D, INTEGRA GRP. Impact of a multicomponent healthcare intervention on glycaemic control in subjects with poorly controlled type 2 diabetes: The INTEGRA study. DIABETES OBESITY & METABOLISM. 2023; 25(4). DOI:10.1111/dom.14951. PMID:36546592. IF:5,400 (Q1/2D). Document type: Article.
-Mollo A, Vlacho B, Gratacos M, Mata M, Rubinat E, Osso AB, Cos FX, Franch J, Khunti K, Mauricio D. A multicomponent health care intervention is associated with improved glycaemic control in subjects with poorly controlled type 2 diabetes compared with routine care: The INTEGRA study. DIABETES OBESITY & METABOLISM. 2023; 25(12). DOI:10.1111/dom.15250. PMID:37608473. IF:5,400 (Q1/2D). Document type: Article.
-Monroy G, Fernández C, Olmo R, Martínez MJ, DE Leiva A, Corcoy R. Breastfeeding is associated with a delayed decrease in postprandial maternal glucose concentration. Minerva Endocrinology. 2023; 48(4). DOI:10.23736/S2724-6507.23.03962-3. PMID:37158811. IF:2,500 (Q3/7D). Document type: Article.
-Muller D, Freemantle N, Bonadonna RC, Mauquoi C, Bigot G, Bonnemaire M, Gourdy P, Mauricio D. Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database. Diabetes Therapy. 2023; 14(2). DOI:10.1007/s13300-022-01356-3. PMID:36596946. IF:2,800 (Q3/6D). Document type: Article.
-Munoz JP, Sanchez P, Diarte E, Zorzano A, Blanco F, Julve J. FTY720-P, a Biased S1PR Ligand, Increases Mitochondrial Function through STAT3 Activation in Cardiac Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(8):7374. DOI:10.3390/ijms24087374. PMID:37108539. IF:4,900 (Q1/3D). Document type: Article.
-Navas M, Almendra R, Puertas L, Jimenez F, Julve J, Perez B, Consegal M, Kassan M, Martinez J, Rodriguez C, Galan M. Targeting mitochondrial stress with Szeto-Schiller 31 prevents experimental abdominal aortic aneurysm: Crosstalk with endoplasmic reticulum stress. BRITISH JOURNAL OF PHARMACOLOGY. 2023; 180(17). DOI:10.1111/bph.16077. PMID:36964990. IF:6,800 (Q1/1D). Document type: Article.
-Nino J, Rojo MI, Martinez P, Rossell J, Ruiz AJ, Alonso N, Ramos B, Mauricio D, Julve J. NAD plus Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota. Nutrients. 2023; 15(13):2992. DOI:10.3390/nu15132992. PMID:37447318. IF:4,800 (Q1/2D). Document type: Review.
-Niño-Narvión J, Camacho M, Julve J. NAD+ Precursors: A Physiological Reboot? Nutrients. 2023; 15(20):4479. DOI: 10.3390/nu15204479. PMID: 37892554. IF:4,800 (Q1/2D). Document type: Editorial Material.
-Ortega E, Vlacho B, Treserres RP, Mata M, Altes A, Mauricio D, Franch J. Severe hypertriglyceridemia prevalence at a primary care setting in Catalonia, Spain. Journal of Clinical Lipidology. 2023; 17(6). DOI:10.1016/j.jacl.2023.09.002. PMID:37741728. IF:3,600 (Q2/3D). Document type: Article.
-Padro T, López A, Pérez A, Vilahur G, Badimon L. Dietary ?3 Fatty Acids and Phytosterols in the Modulation of the HDL Lipidome: A Longitudinal Crossover Clinical Study. Nutrients. 2023; 15(16):3637. DOI:10.3390/nu15163637. PMID:37630826. IF:4,800 (Q1/2D). Document type: Article.
-Pedro J, Barrios V, Sánchez V, Tamargo J, Arrieta F, Gámez JM, Gimeno JA, Escobar C, Gómez JJ, Pérez A, en nombre S. Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología. Endocrinologia Diabetes y Nutricion. 2023; 70. DOI:10.1016/j.endinu.2022.03.004. IF:1,800 (Q3/8D). Document type: Article.
-Pedro J, Barrios V, Sánchez V, Tamargo J, Arrieta F, Gámez JM, Gimeno JA, Escobar C, Gómez JJ, Pérez A, Working Groups of Cardiovascular Pharmacotherapy of the Sociedad Española de Ca . Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología [Spanish Society of Cardiology] and the Sociedad Española de Diabetes [Spanish Diabetes Society]. Endocrinologia Diabetes y Nutricion. 2023; 70(Suppl.1). DOI:10.1016/j.endien.2022.11.009. PMID:36402735. IF:1,800 (Q3/8D). Document type: Article.
-Pennells L, Kaptoge S, Ostergaard HB, Read SH, Carinci F, Franch J, Petitjean C, Taylor O, Hageman SHJ, Xu Z, Shi FC, Spackman S, Gualdi S, Holman N, Costa R, Bonnet F, Brenner H, Kiechl S, Lawlor DA, Potier L, Schottker B, Sofat R, Volzke H, Willeit J, Baltane Z, Fava S, Janos S, Lavens A, Pildava S, Poljicanin T, Pristas I, Rossing P, Sascha R, Scheidt C, Stotl I, Tibor G, Urbancic V, Vanherwegen AS, Vistisen D, Du Y, Walker MR, Willeit P, Ference B, De Bacquer D, Halle M, Huculeci R, McEvoy JW, Timmis A, Vardas P, Dorresteijn J, Graham I, Wood A, Eliasson B, Herrington W, Danesh J, Mauricio D, Benedetti MM, Sattar N, Visseren FLJ, Wild S, Di E, Balkau B, Fumeron F, Stocker H, Holleczek B, Schipf S, Schmidt CO, Doerr M, Tilg H, Leitner C, Notdurfter M, Taylor J, Dale C, Prieto D, Gillum RF, Buble T, Ivanko P, Carstensen B, Heidemann C, Gall T, Sandor J, Lepiksone J, Magri CJ, Azzopardi J, Real J, Vlacho B, Mata M, SCORE2 GRP, ESC Cardiovasc Risk C, ERFC I, SIDIAP I. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. EUROPEAN HEART JOURNAL. 2023; 44(28). DOI:10.1093/eurheartj/ehad260. PMID:37247330. IF:38,100 (Q1/1D). Document type: Article.
-Pérez A, Redondo J, Romera I, Lizán L, Santos MRD, Díaz S, Orozco D. Disease and Economic Burden of Poor Metabolic and Weight Control in Type 2 Diabetes in Spain: A Systematic Literature Review. Diabetes Therapy. 2023; DOI:10.1007/s13300-023-01503-4. PMID:37989829. IF:2,800 (Q3/6D). Document type: Review.
-Reis A, Rocha S, Dias IH, Costa R, Soares R, Sánchez JL, Perez A, de Freitas V. Type 2 Diabetes mellitus alters the cargo of (poly)phenol metabolome and the oxidative status in circulating lipoproteins. Redox Biology. 2023; 59:102572. DOI:10.1016/j.redox.2022.102572. PMID:36516720. IF:10,700 (Q1/1D). Document type: Article.
-Revilla G, Al Qtaish N, Caruana P, Sainz M, Lopez T, Rodriguez F, Paez V, Li CD, Vallverdú NF, Edwards M, Moral A, Pérez JI, Escolà JC, Pedraz JL, Gallego I, Corcoy R, Céspedes MV, Puras G, Mato E. Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior. Biomolecules. 2023; 13(11):1647. DOI:10.3390/biom13111647. PMID:38002329. IF:4,800 (Q1/3D). Document type: Article.
-Revilla G, Ruiz L, Vallverdu NF, Santamaria P, Moral A, Perez JI, Li CD, Fuste V, Lerma E, Corcoy R, Pitoia F, Escola JC, Mato E. Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(13):11153. DOI:10.3390/ijms241311153. PMID:37446330. IF:4,900 (Q1/3D). Document type: Article.
-Rodriguez R, Granado M, de Oca A, Julian MT, Domingo M, Codina P, Santiago E, Cediel G, Julve J, Rossell J, Masana L, Mauricio D, Lupon J, Bayes A, Alonso N. Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus. Antioxidants. 2023; 12(3):645. DOI:10.3390/antiox12030645. PMID:36978893. IF:6,000 (Q1/2D). Document type: Article.
-Rojo MI, Bermúdez M, Castro E, Farràs C, Torres G, Pamplona R, Lecube A, Valdivielso JM, Fernández E, Julve J, Castelblanco E, Franch J, Alonso N, Granado M, Mauricio D, Miquel E, Ortega M, Barbé F, González J, Barril S, Sánchez M, Portero M, Jové M, Hernández M, Rius F, Godoy P, Alonso MM, ILERVAS C. Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort. ATHEROSCLEROSIS. 2023; 380:117191. DOI:10.1016/j.atherosclerosis.2023.117191. PMID:37586219. IF:4,900 (Q1/2D). Document type: Article.
-Rossell J, Rojo MI, Julve J, Mauricio D. The Bittersweet Beat: Diabetes Complications. Journal of Clinical Medicine. 2023; 12(12):4018. DOI:10.3390/jcm12124018. PMID:37373711. IF:3,000 (Q1/2D). Document type: Editorial Material.
-Roth L, Dogan S, Tuna BG, Aranyi T, Benitez S, Borrell M, Bozaykut P, De Meyer GRY, Duca L, Durmus N, Fonseca D, Fraenkel E, Gillery P, Giudici A, Jaisson S, Johansson M, Julve J, Lucas AK, Martinet W, Maurice P, McDonnell BJ, Ozbek EN, Pucci G, Pugh C, Rochfort KD, Roks A, Rotllan N, Shadiow J, Sohrabi Y, Spronck B, Szeri F, Terentes D, Aydin ET, Tura O, Ucar E, Yetik G. Pharmacological modulation of vascular ageing: A review from VascAgeNet. AGEING RESEARCH REVIEWS. 2023; 92:102122. DOI:10.1016/j.arr.2023.102122. PMID:37956927. IF:12,500 (Q1/1D). Document type: Review.
-Sánchez E, Sánchez M, López C, Bermúdez M, Valdivielso JM, Farras C, Pamplona R, Torres G, Mauricio D, Castro E, Fernández E, Lecube A. Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project. Nutrients. 2023; 15(1):203. DOI:10.3390/nu15010203. PMID:36615860. IF:4,800 (Q1/2D). Document type: Article.
-Sanjurjo L, Castelblanco E, Julve J, Villalmanzo N, Tellez E, Ramirez A, Alonso N, Mauricio D, Sarrias MR. Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation: A Role for PRAS40/Akt-Dependent Shedding of Soluble CD14. Antioxidants. 2023; 12(5):1083. DOI:10.3390/antiox12051083. PMID:37237950. IF:6,000 (Q1/2D). Document type: Article.
-Simo R, Franch J, Vlacho B, Real J, Amado E, Flores J, Mata M, Ortega E, Rigla M, Valles J-A, Hernandez C, Mauricio D. Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes. DIABETES CARE. 2023; 46(9). DOI:10.2337/dc22-2521. PMID:37428631. IF:14,800 (Q1/1D). Document type: Article.
-Sprankel L, Vizarraga D, Martín J, Manger S, Meier J, Marcos M, Julve J, Rotllan N, Scheffer MP, Escolà JC, Langer JD, Piñol J, Fita I, Frangakis AS. Essential protein P116 extracts cholesterol and other indispensable lipids for Mycoplasmas. NATURE STRUCTURAL & MOLECULAR BIOLOGY. 2023; 30(3). DOI:10.1038/s41594-023-00922-y. PMID:36782049. IF:12,500 (Q1/1D). Document type: Article.
-Tejera C, Chico A, Azriel S, Lardies B, Gomez F, Area S. Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN). Diabetes Therapy. 2023; 14(7). DOI:10.1007/s13300-023-01417-1. PMID:37188930. IF:2,800 (Q3/6D). Document type: Article.
-Tobias DK, Merino J, Ahmad A, Aiken C, Benham JL, Bodhini D, Clark AL, Colclough K, Corcoy R, Cromer SJ, Duan D, Felton JL, Francis EC, Gillard P, Gingras V, Gaillard R, Haider E, Hughes A, Ikle JM, Jacobsen LM, Kahkoska AR, Kettunen JLT, Kreienkamp RJ, Lim LL, Männistö J, Massey R, Mclennan NM, Miller RG, Morieri ML, Most J, Naylor RN, Ozkan B, Patel KA, Pilla SJ, Prystupa K, Raghavan S, Rooney MR, Schön M, Semnani Z, Sevilla M, Svalastoga P, Takele WW, Tam CH, Thuesen A, Tosur M, Wallace AS, Wang CC, Wong JJ, Yamamoto JM, Young K, Amouyal C, Andersen MK, Bonham MP, Chen M, Cheng F, Chikowore T, Chivers SC, Clemmensen C, Dabelea D, Dawed AY, Deutsch AJ, Dickens LT, DiMeglio LA, Dudenhöffer M, Evans C, Fernández MM, Fitipaldi H, Fitzpatrick SL, Gitelman SE, Goodarzi MO, Grieger JA, Guasch M, Habibi N, Hansen T, Huang C, Harris A, Ismail HM, Hoag B, Johnson RK, Jones AG, Koivula RW, Leong A, Leung GKW, Libman IM, Liu K, Long SA, Lowe WLJR, Morton RW, Motala AA, Onengut S, Pankow JS, Pathirana M, Pazmino S, Perez D, Petrie JR, Powe CE, Quinteros A, Jain R, Ray D, Ried M, Saeed Z, Santhakumar V, Kanbour S, Sarkar S, Monaco GSF, Scholtens DM, Selvin E, Sheu WH, Speake C, Stanislawski MA, Steenackers N, Steck AK, Stefan N, STØYJ, Taylor R, Tye SC, Ukke GG, Urazbayeva M, Van der Schueren B, Vatier C, Wentworth JM, Hannah W, White SL, Yu G, Zhang Y, Zhou SJ, Beltrand J, Polak M, Aukrust I, de Franco E, Flanagan SE, Maloney KA, McGovern A, Molnes J, Nakabuye M, Njølstad PR, Pomares H, Provenzano M, Saint C, Zhang C, Zhu Y, Auh S, de Souza R, Fawcett AJ, Gruber C, Mekonnen EG, Mixter E, Sherifali D, Eckel RH, Nolan JJ, Philipson LH, Brown RJ, Billings LK, Boyle K, Costacou T, Dennis JM, Florez JC, Gloyn AL, Gomez MF, Gottlieb PA, Greeley S, Griffin K, Hattersley AT, Hirsch IB, Hivert MF, Hood KK, Josefson JL, Kwak SH, Laffel LM, Lim SS, Loos RJF, Ma RCW, Mathieu C, Mathioudakis N, Meigs JB, Misra S, Mohan V, Murphy R, Oram R, Owen KR, Ozanne SE, Pearson ER, Perng W, Pollin TI, Pop R, Pratley RE, Redman LM, Redondo MJ, Reynolds RM, Semple RK, Sherr JL, Sims EK, Sweeting A, Tuomi T, Udler MS, Vesco KK, Vilsbøll T, Wagner R, Rich SS, Franks PW. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. NATURE MEDICINE. 2023; 29(10). DOI:10.1038/s41591-023-02502-5. PMID:37794253. IF:58,700 (Q1/1D). Document type: Article.
-Torres JK, Niño J, Martinez P, Diarte EMG, Méndez KA, del Olmo TV, Rotllan N, Julián MT, Alonso N, Mauricio D, Camacho M, Muñoz JP, Rossell J, Julve J. Nicotinamide Prevents Diabetic Brain Inflammation via NAD+-Dependent Deacetylation Mechanisms. Nutrients. 2023; 15(14):3083. DOI:10.3390/nu15143083. PMID:37513501. IF:4,800 (Q1/2D). Document type: Article.
-Velilla TA, Guijarro C, Ruiz RC, Pinero MR, Marcos JFV, Perez AP, Lopez M, Lopez AM, Donaire J, Obaya JC, Guerra LC, Carratala VP, Cabello IE, Lazo MS, Rodrigo MMC, Prieto JMM, Doblas JJG, Soto AB, Multidisciplinar GRP. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile? Clinica E Investigacion En Arteriosclerosis. 2023; 35(2). DOI:10.1016/j.arteri.2022.10.002. PMID:36925360. IF:1,900 (Q3/6D). Document type: Article.
-Velilla TA, Guijarro C, Ruiz RC, Piñero MR, Marcos JF, Pérez AP, López A, López AM, Donaire J, Obaya JC, Guerra LC, Carratalá VP, Cabello IE, Lazo MS, Rodrigo MMC, Prieto JMM, Doblas JJG, Soto AB, Multidisciplinary F. Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: what parameters should a basic lipid profile include?. ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO. 2023; 4(2). DOI:10.1515/almed-2023-0047. PMID:38075943. IF:1,100 (Q3/8D). Document type: Article.
-Velilla TA, Guijarro C, Ruiz RC, Piñero MR, Marcos JFV, Pérez AP, López MAB, López AM, Donaire JAG, Obaya JC, Guerra LC, Carratalá VP, Cabello IE, Lazo MS, Rodrigo MMC, Prieto JMM, Doblas JJG, Soto AB, en representacion Y. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should a basic lipid profile include? Neurology Perspectives. 2023; 3(2):100126. DOI:10.1016/j.neurop.2023.100126. Document type: Article.
-Vlacho B, Mata M, Fernandez B, Liebana LR, Barrot J, Franch J. Adherence to the therapeutic guidelines recommendations among the people with type 2 diabetes mellitus and obesity, frailty, or recent diagnosis, attended in primary health care centers in Spain: A cross-sectional study. Frontiers in Medicine. 2023; 10:1138956. DOI:10.3389/fmed.2023.1138956. PMID:37035300. IF:3,100 (Q1/2D). Document type: Article.
-Xie X, Liu J, García A, Chico A, Mateu M, Amigó J, Adelantado JM, Corcoy R. Gestational weight gain and pregnancy outcomes in women with type 1 and type 2 diabetes mellitus. ACTA DIABETOLOGICA. 2023; 60(5). DOI:10.1007/s00592-023-02031-0. PMID:36707439. IF:3,100 (Q2/5D). Document type: Article.
-Xie X, Liu J, García A, Chico A, Mateu M, Amigó J, Adelantado JM, Corcoy R. Gestational weight gain in women with type 1 and type 2 diabetes mellitus is related to both general and diabetes-related clinical characteristics. Hormones-International Journal of Endocrinology and Metabolism. 2023; DOI:10.1007/s42000-023-00497-9. PMID:37845472. IF:2,400 (Q3/7D). Document type: Article.
(JIF 2022)